Article thumbnail

Analysis of the overall survival of patients with varying immunoreactivities of tumor tissues for IL6 expression.

By Chih-Jung Chen (207116), Wen-Wei Sung (122706), Yueh-Min Lin (297900), Mu-Kuan Chen (155094), Ching-Hsiao Lee (297903), Huei Lee (122731), Kun-Tu Yeh (62596) and Jiunn-Liang Ko (297905)


<p>(A) Kaplan-Meier survival curves for OSCC patients who were classified with either low/negative (weak (1+) or negative (−) IHC positivity) or high IL6 (strong (3+) or moderate (2+) IHC positivity) expression. The IL6 status was not significantly associated (log-rank, P = 0.134) with patient survival. (B) In male OSCC patients, the IL6 status was significantly associated (log-rank, P = 0.014) with patient survival. (C) In female OSCC patients, no significant association was found for IL6 expression and patient survival (log-rank, P = 0.959).</p

Topics: Medicine, Cell Biology, Physiology, Cancer, patients, varying, immunoreactivities, tissues, il6
Year: 2013
DOI identifier: 10.1371/journal.pone.0050104.g003
OAI identifier:
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.